On a Tuesday morning in the District, Mayor Muriel Bowser stood behind a proposal that would have sounded almost impossible five years ago: letting local breweries and distilleries team up with medical cannabis companies to make THC-infused drinks.

The Medical Cannabis Beverage Product Amendment Act of 2026 is now before the Council of the District of Columbia, and it signals something that cannabis advocates in markets like Humboldt have been watching play out across the country. Even in cities where full recreational sales remain blocked, officials are finding creative ways to expand what medical cannabis looks like.

The setup Bowser is proposing is straightforward enough. Alcohol companies could apply for a medical cannabis production endorsement for $500 a year, and medical marijuana companies could apply for a $1,000 annual endorsement to import cannabinoids for production. All beverages would need to pass testing through a locally licensed laboratory, and a six percent sales tax would apply to sales.

“This is an opportunity to support two local industries and to keep business in D.C.,” Bowser said in a statement. “We have fantastic local brewers and distillers in our city, we have a robust medical cannabis market, and this is a new opportunity for those two markets to collaborate and create a safe and smoke-free alternative for patients in D.C.”

There are guardrails built into the proposal that keep it squarely in medical territory. Breweries and distilleries would not be able to sell directly to consumers. Finished products would move to partnering medical marijuana manufacturers for testing and distribution. And sales would be limited to registered medical cannabis patients through dispensaries. Bars, restaurants, liquor stores, and grocery stores are all off the table.

Fred Moosally, Director of the Alcoholic Beverage and Cannabis Administration, said the partnership makes sense for D.C.’s evolving market. “Providing a legal pathway for our local breweries and distilleries to apply their expertise in beverage production is the logical next step in maturing D.C.’s medical cannabis marketplace and supporting our local business ecosystem,” he said.

The proposal comes with an unusual policy constraint shaping every decision D.C. makes around cannabis. Congress has repeatedly blocked the District from legalizing recreational marijuana sales through an annually renewed budget rider. Local officials have no vote in that process. So while states like California, Oregon, and Colorado moved forward with full recreational markets years ago, D.C. has been left operating a medical cannabis system and navigating a gray-market of gifting storefronts that emerged after voters approved legalization in 2015 without the commercial structure to support it.

What Bowser and city officials have done in that constraint is get creative. D.C. already allows residents and visiting tourists to self-certify as medical cannabis patients without a doctor’s recommendation, an approach designed to widen access within the existing legal framework. The beverage proposal follows the same logic: work with what you have, expand the options, and support local businesses while doing it.

From a California perspective, the conversation about cannabis beverages looks a little different. California has had a functioning recreational market for years, and THC drinks have carved out a real presence in dispensary cases across the state, including up here in Humboldt. The category has grown as consumers look for alternatives to smoking and for products that fit social occasions without the complications of alcohol. There’s a ritual familiarity to cracking open a can that a tincture or an edible doesn’t quite replicate.

That’s a big part of what D.C. is recognizing in this proposal. The mayor’s office framed it as a solution to manufacturing challenges in the medical cannabis space, noting that local bottling infrastructure from the craft beverage industry could support production at a scale that many cannabis operations can’t achieve on their own. For D.C.’s smaller medical cannabis businesses, partnering with an established brewery or distillery offers something real: production capacity, equipment, and expertise in producing shelf-stable, consistently dosed drinks.

The cross-industry angle is genuinely interesting. Cannabis and alcohol have often been positioned as competitors, especially as cannabis beverage sales have pulled some consumers away from alcohol entirely. Studies and sales data over the past several years have pointed to that substitution effect in legal states. But what Bowser is proposing is less a competition and more a production partnership, one where alcohol companies stay in their lane as manufacturers and cannabis companies maintain control of distribution and access.

Whether the D.C. Council moves the bill forward quickly or lets it sit is an open question. D.C. politics around cannabis have moved in starts and stops, and anything touching the industry carries the added uncertainty of Congressional oversight.

But the direction of the proposal tells a story that’s familiar to anyone following cannabis policy nationally. The drink is already here. Consumers already want it. The infrastructure to make it well already exists in most cities. The last piece, most of the time, is just getting policy to catch up to the reality of what people are already reaching for when they walk into a dispensary.

In D.C., that last piece just got a little closer.